We report on the fabrication of the first micro/nanoscale MC receiver based on graphene field-effect transistor biosensors.
Our project 'REINFORMATION' has been awarded the MSCA Individual Fellowship!
[join us!]
Applications are invited for fully-funded MSc and PhD positions!
[Molecular Communications getting practical with GRAPHENE]
We report on the first micro/nanoscale MC receiver based on graphene.
[See recent publications]
Our current research activities at CALICO Lab revolve around the Internet of Bio-Nano Things (IoBNT), an emerging information and communication technology (ICT) framework aiming at extending our connectivity and control to NANOscale and BIOlogical environments with collaborative networks of artificial nanomachines and biological entities.
At the intersection of ICT, nanotechnology and biotechnology, we conduct highly interdisciplinary theoretical and experimental research with the objective of realizing the futuristic medical, environmental, and industrial applications of the IoBNT.
IoBNT is nonconventional in every respect: nonconventional things (e.g., engineered bacteria, nanobiosensors, nanoparticles) coordinated via nonconventional communication methods (e.g., molecular communications) in nonconventional environments (e.g., inside human body) for nonconventional applications (e.g., continuous intrabody health monitoring, smart drug delivery without side effects).
Our quest to develop practical IoBNT applications bears many challenges, that can basically be worded in questions such as
To target these challenges, we follow a highly interdisciplinary methodology integrating expertise in ICT, molecular communications, microfluidics, nanobiosensors, graphene and related nanomaterials. We are currently
Just as the overarching endeavour of space exploration has given rise to countless spinoff technologies exploited mostly in other areas, e.g., cochlear implants and CMOS image sensors, so our interdisciplinary quest to develop practical IoBNT applications is hoped to have far-reaching impact on, for example, microfluidic drug delivery, biosensing for dynamic biomarkers, ICT understanding of biological systems, multiplexed biosensing, development of new diagnosis and treatment techniques, and many more.